FOLH1 and posterior cortical atrophy: Clinical trials correlating PSMA-PET-positive findings with histopathology from pelvic lymph node dissection in intermediate- to high-risk PCa patients showed somewhat poorer performance on a region level with a sensitivity between 40% and 66% and a specificity between 95% and 98% (4, 5).